Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

Locally Advanced ◽

Phase II study of neoadjuvant gemcitabine (GC), pegylated liposomal doxorubicin (DX) and docetaxel (TT) in locally advanced breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.606 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 606-606

Author(s):

G. Cartei ◽

L. Borgato ◽

G. Lombardi ◽

A. Cappetta ◽

F. Bozza ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

434 Phase II Study of Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/− Trastuzumab Followed by Docetaxel in Locally Advanced Breast Cancer (LABC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)70500-2 ◽

2012 ◽

Vol 48 ◽

pp. S173

Author(s):

M.K. Tuxen ◽

S. Cold ◽

U.B. Tange ◽

S.B. Soendergaard ◽

D.L. Nielsen

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group

Annals of Oncology ◽

10.1093/annonc/mdf284 ◽

2002 ◽

Vol 13 (11) ◽

pp. 1737-1742 ◽

Cited By ~ 46

Author(s):

H. Gogas ◽

C. Papadimitriou ◽

H.P. Kalofonos ◽

D. Bafaloukos ◽

G. Fountzilas ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Locally Advanced ◽

Oncology Group

225P Phase II study of pyrotinib plus albumin-bound paclitaxel and trastuzumab as neoadjuvant treatment in HER2-positive early or locally advanced breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.346 ◽

2020 ◽

Vol 31 ◽

pp. S331

Author(s):

T. Luo ◽

X. Zhong ◽

P. He ◽

X. Yan ◽

T. Tian ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Breast ◽

Her2 Positive

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study

Oncotarget ◽

10.18632/oncotarget.17954 ◽

2017 ◽

Vol 8 (45) ◽

pp. 79305-79314 ◽

Cited By ~ 12

Author(s):

Liheng Zhou ◽

Shuguang Xu ◽

Wenjin Yin ◽

Yanpin Lin ◽

Yueyao Du ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

Phase II study of neoadjuvant gemcitabine, epirubicin, and albumin-bound nab paclitaxel (GEA) in locally advanced breast cancer with SPARC tumor assessments

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.603 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 603-603 ◽

Cited By ~ 2

Author(s):

D. A. Yardley ◽

R. C. Inhorn ◽

D. Daniel ◽

B. Daniel ◽

Y. Naot ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Prospective phase II study of: neo-adjuvant doxorubicin followed sequentially by cisplatin/docetaxel in locally advanced breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80392-7 ◽

2006 ◽

Vol 4 (2) ◽

pp. 157

Author(s):

T. Al-Tweigeri ◽

Rahal ◽

D. Ajarim ◽

A. Al-Sayed ◽

A. Tulba ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Prospective Phase

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-006-0236-3 ◽

2006 ◽

Vol 58 (6) ◽

pp. 742-748 ◽

Cited By ~ 14

Author(s):

Alexandros Ardavanis ◽

Dimitris Mavroudis ◽

Kostas Kalbakis ◽

Nikolaos Malamos ◽

Kostas Syrigos ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Salvage Treatment ◽

Advanced Breast ◽

Multicentre Phase ◽

Pretreated Patients

Epirubicin and Docetaxel as Neoadjuvant Treatment of Locally Advanced Breast Cancer: A Phase II Study

Tumori Journal ◽

10.1177/030089161009600207 ◽

2010 ◽

Vol 96 (2) ◽

pp. 229-233 ◽

Cited By ~ 2

Author(s):

Davide Lombardi ◽

Simona Scalone ◽

Diana Crivellari ◽

Maria Donatella Magri ◽

Nicoletta La Mura ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer

The Breast ◽

10.1016/j.breast.2011.02.014 ◽

2011 ◽

Vol 20 (4) ◽

pp. 319-323 ◽

Cited By ~ 26

Author(s):

Silvia Dellapasqua ◽

Manuelita Mazza ◽

Debora Rosa ◽

Raffaella Ghisini ◽

Eloise Scarano ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Low Dose ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽

Advanced Breast ◽

Preoperative Treatment ◽

Metronomic Cyclophosphamide